Clinical Oncology Next Generation Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Clinical Oncology Next Generation Market, By Technology

7.1.  Clinical Oncology Next Generation Market, By Technology Type, 2020-2030

7.1.1.    Whole Genome Sequencing

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Whole Exome Sequencing

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Targeted Sequencing & Resequencing Centrifuges

7.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Clinical Oncology Next Generation Market, By Workflow

8.1.  Clinical Oncology Next Generation Market, By Workflow, 2020-2030

8.1.1.    Pre-Sequencing

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Sequencing

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Data Analysis

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Clinical Oncology Next Generation Market, By Application Type

9.1.  Clinical Oncology Next Generation Market, By Application Type, 2020-2030

9.1.1.    Screening

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Companion Diagnostics

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Other  Diagnostics

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Clinical Oncology Next Generation Market, By End-use Type

10.1.        Clinical Oncology Next Generation Market, By End-use Type, 2020-2030

10.1.1.  Hospitals

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Clinics

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Laboratories

10.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Clinical Oncology Next Generation Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, By Technology (2016-2030)

11.1.2.  Market Revenue and Forecast, By Workflow (2016-2030)

11.1.3.  Market Revenue and Forecast, By Application Type (2016-2030)

11.1.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, By Technology (2016-2030)

11.1.5.2.      Market Revenue and Forecast, By Workflow (2016-2030)

11.1.5.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.1.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, By Technology (2016-2030)

11.1.6.2.      Market Revenue and Forecast, By Workflow (2016-2030)

11.1.6.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.1.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, By Technology (2016-2030)

11.2.2.  Market Revenue and Forecast, By Workflow (2016-2030)

11.2.3.  Market Revenue and Forecast, By Application Type (2016-2030)

11.2.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, By Technology (2016-2030)

11.2.5.2.      Market Revenue and Forecast, By Workflow (2016-2030)

11.2.5.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.2.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, By Technology (2016-2030)

11.2.6.2.      Market Revenue and Forecast, By Workflow (2016-2030)

11.2.6.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.2.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, By Technology (2016-2030)

11.2.7.2.      Market Revenue and Forecast, By Workflow (2016-2030)

11.2.7.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.2.7.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, By Technology (2016-2030)

11.2.8.2.      Market Revenue and Forecast, By Workflow (2016-2030)

11.2.8.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.2.8.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, By Technology (2016-2030)

11.3.2.  Market Revenue and Forecast, By Workflow (2016-2030)

11.3.3.  Market Revenue and Forecast, By Application Type (2016-2030)

11.3.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, By Technology (2016-2030)

11.3.5.2.      Market Revenue and Forecast, By Workflow (2016-2030)

11.3.5.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.3.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, By Technology (2016-2030)

11.3.6.2.      Market Revenue and Forecast, By Workflow (2016-2030)

11.3.6.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.3.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, By Technology (2016-2030)

11.3.7.2.      Market Revenue and Forecast, By Workflow (2016-2030)

11.3.7.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.3.7.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, By Technology (2016-2030)

11.3.8.2.      Market Revenue and Forecast, By Workflow (2016-2030)

11.3.8.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.3.8.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, By Technology (2016-2030)

11.4.2.  Market Revenue and Forecast, By Workflow (2016-2030)

11.4.3.  Market Revenue and Forecast, By Application Type (2016-2030)

11.4.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, By Technology (2016-2030)

11.4.5.2.      Market Revenue and Forecast, By Workflow (2016-2030)

11.4.5.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.4.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, By Technology (2016-2030)

11.4.6.2.      Market Revenue and Forecast, By Workflow (2016-2030)

11.4.6.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.4.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, By Technology (2016-2030)

11.4.7.2.      Market Revenue and Forecast, By Workflow (2016-2030)

11.4.7.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.4.7.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, By Technology (2016-2030)

11.4.8.2.      Market Revenue and Forecast, By Workflow (2016-2030)

11.4.8.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.4.8.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, By Technology (2016-2030)

11.5.2.  Market Revenue and Forecast, By Workflow (2016-2030)

11.5.3.  Market Revenue and Forecast, By Application Type (2016-2030)

11.5.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, By Technology (2016-2030)

11.5.5.2.      Market Revenue and Forecast, By Workflow (2016-2030)

11.5.5.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.5.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, By Technology (2016-2030)

11.5.6.2.      Market Revenue and Forecast, By Workflow (2016-2030)

11.5.6.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.5.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

Chapter 12.  Company Profiles

12.1.              Beijing Genomics Institute (BGI)

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Perkin Elmer

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Foundation Medicine

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Pacific Bioscience

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Oxford Nanopore Technologies Ltd.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Paradigm Diagnostics

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Caris Life Sciences

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Partek, Inc.

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Eurofins Scientific S.E.

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Qiagen N.V.

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

14.2.              Glossary of Terms